Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
Published August 19, 2026 · Recall initiated: August 4, 2026
Summary
FDA records drug Class II recall D-0746-2026, published August 19, 2026 and initiated August 4, 2026. Recalling firm: Novartis Pharmaceuticals Corporation; Status: Ongoing; Lot: Lot AV5913C, Expiry: 6/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if DIOVAN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- DIOVAN
- Manufacturer
- Novartis Pharmaceuticals Corporation
- Distributor
- US Nationwide
- Lot
- Lot AV5913C, Expiry: 6/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASEMAGLUTIDE 12.5MG (2.5MG/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLOAugust 19, 2026
- FDASEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only,August 19, 2026
- FDASEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only,August 19, 2026
- FDANeuroguard IEP 3 in 1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic ProtectionAugust 12, 2026
- FDABlom-Singer Classic Indwelling Voice Prosthesis, 16Fr/10 mm REF: 1610-LFAugust 12, 2026
- FDABlom-Singer Classic Indwelling Voice Prosthesis, 16Fr/10 mm REF: 1610-LEFAugust 12, 2026
Questions about this recall
Was Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 recalled?
Yes. FDA published recall D-0746-2026 on August 19, 2026. Reported hazard: Failed Dissolution Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: DIOVAN.